Friday , November 17 2017
Home / Tag Archives: Gilead Sciences

Tag Archives: Gilead Sciences

October, 2017

August, 2017

July, 2017

May, 2017

April, 2017

February, 2017

December, 2016

November, 2016

  • 11 November

    FDA Approves Gilead’s Vemlidy for Treatment of Hepatitis B

    FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vemlidy® (tenofovir alafenamide, TAF) 25mg, a once-daily treatment for adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. Vemlidy has a boxed warning in its product label …

June, 2016